| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/30/2001 | CA2683009A1 Use of il-18 inhibitors |
| 08/30/2001 | CA2437298A1 Method for correlating blood coagulation activity with markers in body fluids, e.g. urine |
| 08/30/2001 | CA2406864A1 Simultaneous stimulation and concentration of cells |
| 08/30/2001 | CA2401868A1 Molecules for diagnostics and therapeutics |
| 08/30/2001 | CA2401647A1 Inter-alpha-trypsin as a marker for sepsis |
| 08/30/2001 | CA2401367A1 Activated vitronectin as a marker of angiogenesis detected with phage antibodies |
| 08/30/2001 | CA2401113A1 Transporters and ion channels |
| 08/30/2001 | CA2401031A1 Tlp peptides and dna sequences coding the same |
| 08/30/2001 | CA2400915A1 Estrogen receptor alpha variants and methods of detection thereof |
| 08/30/2001 | CA2400876A1 Novel protein and gene encoding the protein |
| 08/30/2001 | CA2400874A1 Membrane estrogen receptor-directed therapy in breast cancer |
| 08/30/2001 | CA2400842A1 Novel compounds |
| 08/30/2001 | CA2400831A1 Estrogen receptor beta variants and methods of detection thereof |
| 08/30/2001 | CA2400794A1 New transcription factor carp-2 |
| 08/30/2001 | CA2400710A1 Starch branching enzyme |
| 08/30/2001 | CA2400661A1 Novel antibody with specificity for colon cancer |
| 08/30/2001 | CA2400622A1 Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis |
| 08/30/2001 | CA2400606A1 New phosphodiesterase type 7b |
| 08/30/2001 | CA2400443A1 103p2d6: tissue specific protein highly expressed in various cancers |
| 08/30/2001 | CA2400441A1 Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof |
| 08/30/2001 | CA2399999A1 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 08/30/2001 | CA2399298A1 Use of il-18 inhibitors |
| 08/30/2001 | CA2399255A1 Caspase activated prodrugs therapy |
| 08/30/2001 | CA2398275A1 Human polynucleotides, polypeptides, and antibodies |
| 08/29/2001 | EP1127894A1 Method of diagnosis of transmissible spongiform encephalopathy (TSE) |
| 08/29/2001 | EP1127260A1 Immunotherapy of b cell involvement in progression of solid, nonlymphoid tumors |
| 08/29/2001 | EP1127170A1 Human pan-hcv human monoclonal antibodies |
| 08/29/2001 | EP1127165A1 Method and test kit for analyzing dns repair |
| 08/29/2001 | EP1127142A1 Modulation of polypeptide display on modified filamentous phage |
| 08/29/2001 | EP1127139A2 Compositions and methods for identifying mammalian malonyl coa decarboxylase inhibitors, agonists and antagonists |
| 08/29/2001 | EP1127138A1 Alpha 1,2 fucosyltransferase from helicobacter pylori |
| 08/29/2001 | EP1127133A2 Polypeptide mediating cell permeability |
| 08/29/2001 | EP1127132A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 08/29/2001 | EP1127131A2 Connective tissue growth factor (ctgf) and methods of use |
| 08/29/2001 | EP1127130A1 Murine expression of human immunoglobulin lambda locus |
| 08/29/2001 | EP1127129A1 Myosin heavy chain homolog |
| 08/29/2001 | EP1127128A1 Isolated vshk-1 receptor polypeptides and methods of use thereof |
| 08/29/2001 | EP1127124A2 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
| 08/29/2001 | EP1127123A2 Cell surface glycoproteins |
| 08/29/2001 | EP1127120A1 Genomic and complete cdna sequences of human adipocyte-specific apm1 and biallelic markers thereof |
| 08/29/2001 | EP1127119A1 Compounds and methods for modulating claudin-mediated functions |
| 08/29/2001 | EP1127117A1 Opg fusion protein compositions and methods |
| 08/29/2001 | EP1127116A2 Antigen-binding proteins comprising a linker which confers restricted conformational flexibility |
| 08/29/2001 | EP1127110A1 Modified exosomes and uses |
| 08/29/2001 | EP1127069A2 Biological materials and methods useful in the diagnosis and treatment of prion diseases |
| 08/29/2001 | EP1127067A2 Inhibition of transglutaminase-mediated microbial interaction with a mammalian host |
| 08/29/2001 | EP1127065A2 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
| 08/29/2001 | EP1127064A1 Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 08/29/2001 | EP1126878A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 08/29/2001 | EP1126877A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 08/29/2001 | EP1126864A1 Binding moieties for human parvovirus b19 |
| 08/29/2001 | EP1126863A1 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2 |
| 08/29/2001 | EP0941118B1 Pharmaceutical antigen-antibody preparation |
| 08/29/2001 | EP0846266A4 Differential assay for ulcerative colitis, primary sclerosing cholangitis and type 1 autoimmune hepatitis |
| 08/29/2001 | EP0751709B1 Use of bcl-2 for the manufacture of medicaments for the therapeutic treatment and prevention of diseases |
| 08/29/2001 | CN1310758A Novel method for isolating gene |
| 08/29/2001 | CN1310625A Use of alpha1 & beta1 integrin receptor inhibitors and TGF-beta1 inhibitors in the treatment of kidney disease |
| 08/29/2001 | CN1310185A New human mitoribosome protein L4 and its coding sequence |
| 08/29/2001 | CN1310184A New human transposition chain related membrane protein and its coding sequence |
| 08/29/2001 | CA2335436A1 Novel core 2 beta-1,6-n-acetylglycosaminyl transferase gene |
| 08/28/2001 | US6281336 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
| 08/28/2001 | US6281335 Hybridoma and anti-KC-4 humanized monoclonal antibody |
| 08/28/2001 | US6281332 Hedgehog-derived polypeptides |
| 08/28/2001 | US6281016 Broad-spectrum insect resistant transgenic plants |
| 08/28/2001 | US6280974 Nucleotide sequence coding viral protein; for use as diagnostic tool in detection of viral diseases |
| 08/28/2001 | US6280971 Polynucleotide associated with detection of staphylococcus; for use in screening bactericides |
| 08/28/2001 | US6280958 Detecting preferential antibodies in sample; incubate sample with antigenic protein and detect immune complex |
| 08/28/2001 | US6280957 Preventing graft rejection in humans; administer human a modulator of ligand activity, insert hematopoietic stem cells and graft into human, monitor response to grafts |
| 08/28/2001 | US6280956 Antibodies to bladder cancer nuclear matrix proteins and their use |
| 08/28/2001 | US6280944 Assay for pathogenicity of anti-DNA antibodies |
| 08/28/2001 | US6280938 SCA7 gene and method of use |
| 08/28/2001 | US6280735 Polypeptides of riboflavin specific deaminase family |
| 08/28/2001 | US6280734 Simian-human HAV having a chimeric 2C protein |
| 08/28/2001 | US6280732 Administering intracerebrally al-1 immunoadhesin comprising mature al-1 polypeptide having specified amino acid sequence in amount effective to activate autophosphorylation of rek7 |
| 08/28/2001 | US6280731 Monoclonal antibody which binds to human von willebrand factor, inhibits ristocetin-dependent and botrocetin-dependent binding of human von willebrand factor to human platelets, exhibits antithrombotic action in guinea pigs |
| 08/28/2001 | US6280730 Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin |
| 08/28/2001 | US6280729 Treating christmas disease in patient by administering effective amount of therapeutic composition comprising storage stable aqueous solution of purified factor ix |
| 08/28/2001 | CA2203443C Hepatitis c virus asialoglycoproteins |
| 08/28/2001 | CA2111845C Monoclonal antibodies specific for marrow-derived mesenchymal cells |
| 08/28/2001 | CA2079902C Antibody conjugates for treatment of neoplastic disease |
| 08/28/2001 | CA2054706C Very large scale immobilized polymer synthesis |
| 08/28/2001 | CA1341287C Polypeptides derived from human papillomavirus, antibodies to said polypeptide and detection of human papillomavirus latent proteins |
| 08/23/2001 | WO2001061356A1 Her-2 binding antagonists |
| 08/23/2001 | WO2001061351A1 Method for quantitatively detecting antigen |
| 08/23/2001 | WO2001061055A2 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes |
| 08/23/2001 | WO2001061017A2 Modified cytokines for use in cancer therapy |
| 08/23/2001 | WO2001061009A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061008A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061007A2 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | WO2001060992A2 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 08/23/2001 | WO2001060991A2 Human kinases |
| 08/23/2001 | WO2001060866A1 Anti-viral conjugate comprising a factor allowing the translocation of a protein across a cell membrane and comprising a single-chain antibody fragment directed against a viral protein |
| 08/23/2001 | WO2001060857A2 Compositions useful for regulating parkin gene activity |
| 08/23/2001 | WO2001060852A1 A 52 kDa PROTEIN FROM COAGULASE NEGATIVE STAPHYLOCOCCI AND FRAGMENTS THEREOF |
| 08/23/2001 | WO2001060844A2 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 08/23/2001 | WO2001060838A2 Aids ancestral viruses and vaccines |
| 08/23/2001 | WO2001060406A1 Therapeutic methods that target fractalkine or cx3cr1 |
| 08/23/2001 | WO2001060405A1 Eosinophil-specific apoptosis inducer |
| 08/23/2001 | WO2001060404A2 Use of opri lipoprotein from pseudomonas as a th1 inducing natural adjuvant for heterologous antigens |
| 08/23/2001 | WO2001060401A1 Methods of modulating protease-activated receptor-4 (par4) activation via cathepsin g |